Glycopyrronium + formoterol (Bevespi Aerosphere)
- Status:
- Green
- Decision Date:
- June 2021
Comments
GREEN 2nd line LABA/LAMA:
- Bevespi aerosphere (MDI) (Decision date - June 2021)
- See local COPD guidance. Choice should be based on patient ability to tolerate and use inhaler device.
search again
